Arco Lifesciences (I) Pvt. Ltd. is one of the leading manufacturers of Injectable medicines in Central India, Nagpur. Established in the year of 2004, the company has developed a wide portfolio of generic as well as speciality products, including the specialized Contrast Media injections. Arco Lifesciences is largely engaged in R&D and manufacturing of Small Volume Parenteral (SVP) products along with Speciality Liquid Oral Products.
We have a state of the art sterile manufacturing unit where we manufacture the best quality products for everyone. Being committed to the quality healthcare, we continue to develop specialized products, our Contrast Media range of products stands as an example. We are among the very few Indian companies to have launched and marketed various specialty products viz. X-ray & MRI contrast media products (Ionic & Non-ionic Iodinated contrast media) and many other specialty formulations.
We strictly follow the CGMP and CGLP guidelines to meet the highest level of quality for our products and to comply with the stringent GMP norms. We are an ISO 9001:2015 certified enterprise with a GMP certified manufacturing unit. If there is one attribute which we attach the utmost importance it is quality. Quality is considered paramount for all our operations right from research & development, manufacturing, testing to the distribution of our products. Our operations are driven by best-in-class technology and processes, abiding by major stringent regulatory approvals. Our commitment to implementing a robust quality management system is based on our determination to sustain a culture of excellence, meeting the expectations of our customers. We’re committed to quality healthcare for everyone because every individual
“Healthcare is a very vital and sensitive sector for mankind. It is powerful. Keeping in mind the importance and the impact of healthcare on mankind, Arco is committed to fairly function on strong values and dedication. Plan for Arco is to retain and grow in the pharmaceutical markets keeping our inbound values intact.”